Bristol-Myers Squibb Co (BMY)

Add to Watchlists
Create an Alert
Quickflows
60.96 -1.04  -1.68% NYSE Sep 16, 14:05 USD
View Full Chart
Price Chart
View All Key Stats

Key Stats

View All BMY News

News

View All Events

Events

Date Type Description
10/27/2021 Earnings Results Q3 2021 Earnings Results
10/27/2021 08:00 EST Earnings Calls Q3 2021 Earnings Call
09/30/2021 Dividends 0.49 Normal dividend, declared September 09, 2021 and paid November 01, 2021
07/28/2021 Earnings Results Q2 2021 Earnings Results
07/28/2021 08:00 EST Earnings Calls Q2 2021 Earnings Call
07/01/2021 Dividends 0.49 Normal dividend, declared June 18, 2021 and paid August 02, 2021
05/04/2021 10:00 EST AGM 2020 Annual General Meeting
04/29/2021 Earnings Results Q1 2021 Earnings Results
04/29/2021 09:00 EST Earnings Calls Q1 2021 Earnings Call
03/31/2021 Dividends 0.49 Normal dividend, declared March 01, 2021 and paid May 03, 2021
View All Performance Charts

Total Returns Comparison

Fundamentals

Income Statement View Statement

Revenue (TTM) 44.38B
Total Expenses (TTM) 40.88B
Net Income (TTM) -5.079B

Balance Sheet View Statement

Total Assets (Quarterly) 110.80B
Total Liabilities (Quarterly) 73.92B
Shareholders Equity (Quarterly) 36.81B

Cash Flow Statement View Statement

Cash from Operations (TTM) 12.51B
Cash from Investing (TTM) -11.99B
Cash from Financing (TTM) -9.581B

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, oncology, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
  • URL: http://www.bms.com
  • Investor Relations URL: https://www.bms.com/investors.html
  • HQ State/Province: New York
  • Sector: Healthcare
  • Industry: Drug Manufacturers - General
  • Equity Style: Large Cap/Value
  • Next Earnings Release: Oct. 27, 2021
  • Last Earnings Release: Jul. 28, 2021
  • Next Ex-Dividend Date: Sep. 30, 2021
  • Last Ex-Dividend Date: Jul. 01, 2021

Analyst Coverage

Consensus Recommendations
Buy Recommendations Upgrade
Outperform Recommendations Upgrade
Hold Recommendations Upgrade
Underperform Recommendations Upgrade
Sell Recommendations Upgrade
Consensus Recommendation Upgrade
Consensus Rating Upgrade
Target Price
Price 60.96
Price Target Upgrade
Price Target Upside (Daily) Upgrade

Top Fund Holders

Symbol Name Weighting
VGHCX Vanguard Health Care Inv 3.60%
XLV Health Care Select Sector SPDR® ETF 2.76%
HDV iShares Core High Dividend ETF 2.66%
VHCIX Vanguard Health Care Index Admiral 2.51%
VHT Vanguard Health Care ETF 2.51%
OIEFX JPMorgan Equity Income R2 2.24%
JUEQX JPMorgan US Equity R4 1.80%
VLUE iShares MSCI USA Value Factor ETF 1.63%
DGRO iShares Core Dividend Growth ETF 1.29%
VDADX Vanguard Dividend Appreciation Index Adm 1.25%
VIG Vanguard Dividend Appreciation ETF 1.25%
FCTDX Strategic Advisers® Fidelity US TtlStk 0.54%

Comparables

Edit
GILD Gilead Sciences Inc
JNJ Johnson & Johnson
LLY Eli Lilly and Co
MRK Merck & Co Inc
PFE Pfizer Inc

Other Resources

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.